Calcul Marylene S Fallacy

Use this calculator to understand how a seemingly accurate test can still produce a surprisingly low chance that a positive result means the condition is truly present. This is the heart of Marylene’s fallacy: confusing test accuracy with the real probability after considering base rates.

Calculator Inputs

Results

What this calculator shows

• True positives and false positives in a real population
• The probability that a positive result is actually correct
• How rare conditions can make positive results less trustworthy than expected
• Why base-rate neglect leads to Marylene’s fallacy

Expert Guide to Calcul Marylene’s Fallacy

Marylene’s fallacy can be understood as a practical version of a classic probability error: people often assume that a highly accurate test automatically makes a positive result highly reliable. In reality, the reliability of a positive result depends on more than sensitivity and specificity. It also depends on the underlying prevalence, also called the base rate. The lower the prevalence, the easier it becomes for false positives to compete with or even outnumber true positives. That is why a positive result in a rare-condition setting can be less conclusive than intuition suggests.

This is exactly what the calculator above measures. It uses a standard Bayesian framework to estimate how many people in a population truly have a condition, how many do not, how many true positives appear after testing, and how many false positives are generated by the imperfect test. Once those pieces are known, the key question becomes straightforward: among all positive results, what share are actually correct? That final number is usually called the positive predictive value, or PPV.

Why Marylene’s Fallacy Matters

Marylene’s fallacy matters because it affects how people interpret evidence in medicine, finance, cybersecurity, law, and public policy. Consider a screening test with 95% specificity and 90% sensitivity. Many people hear those figures and assume a positive result means there is around a 90% or 95% chance the person truly has the condition. But if the condition is rare, that conclusion can be badly wrong. In a population where only 1% are affected, even a small false-positive rate applied to the many unaffected people can create a large pool of misleading positive results.

This misunderstanding is not a minor technical issue. It influences real-world decisions such as whether to pursue invasive follow-up care, whether to freeze a bank account for suspected fraud, whether to escalate a security alert, or whether to treat probabilistic evidence as definitive proof. The calculator helps correct this error by translating abstract percentages into counts people can see and compare.

The Formula Behind the Calculation

The core formula is Bayes’ theorem. In this context, it answers:

Probability of condition given a positive result

Mathematically, the PPV can be written as:

PPV = (Sensitivity × Prevalence) / [(Sensitivity × Prevalence) + ((1 – Specificity) × (1 – Prevalence))]

Each term matters:

• Prevalence tells you how common the condition is before any testing.
• Sensitivity tells you how often real cases are correctly caught.
• Specificity tells you how often non-cases are correctly cleared.
• False-positive rate is simply 1 minus specificity.

The calculator also converts percentages into expected counts. That is useful because frequency formats are often easier to understand than percentages. For example, in a population of 10,000 with 1% prevalence, there are about 100 true cases. If the test sensitivity is 90%, about 90 of those 100 are flagged positive. But among the 9,900 unaffected people, a 5% false-positive rate creates about 495 false positives. Suddenly the result looks very different: among 585 total positive results, only 90 are true positives. The PPV is therefore about 15.38%, not 90%.

Worked Example: Why a Good Test Can Still Mislead

Suppose a disease affects 1% of the population. A screening test has 90% sensitivity and 95% specificity. In a group of 10,000 people:

1. Expected true cases: 1% of 10,000 = 100
2. Expected non-cases: 9,900
3. True positives: 90% of 100 = 90
4. False negatives: 10
5. False positives: 5% of 9,900 = 495
6. True negatives: 9,405

Now ask the most important practical question: if a person tests positive, what is the chance the person really has the disease? The answer is 90 divided by 585, or approximately 15.38%. This is the essence of Marylene’s fallacy. A strong test characteristic does not guarantee a strong post-test probability when prevalence is low.

Comparison Table: Same Test, Different Prevalence

The table below illustrates how the exact same test can lead to very different interpretations depending on the base rate. The numbers assume a test with 90% sensitivity and 95% specificity in a population of 10,000.

Prevalence	True Positives	False Positives	Total Positives	PPV
0.1%	9	500	509	1.77%
1%	90	495	585	15.38%
5%	450	475	925	48.65%
10%	900	450	1,350	66.67%

This table demonstrates a central insight: raising prevalence dramatically improves the probability that a positive result is meaningful, even when the test itself does not change.

Where People Encounter This Fallacy

Although health screening is the most common teaching example, the same logic appears in many fields:

• Medical testing: Screening large low-risk populations often generates many false positives unless confirmatory testing follows.
• Fraud detection: If actual fraud is rare, an alert system can flag many legitimate transactions despite high apparent accuracy.
• Security monitoring: Intrusion detection tools may generate alert fatigue because true attacks are uncommon compared with benign traffic.
• Legal reasoning: Rare-match evidence can be misunderstood if the probability of innocence is not accounted for properly.
• Hiring or admissions models: Classification tools can be misinterpreted when one outcome class is much rarer than the other.

Comparison Table: Real-World Screening Statistics

Real screening programs differ in accuracy and target populations. The numbers below are broad reference figures commonly discussed in public-health literature and are presented to show why context matters. Exact performance varies by age, methodology, and population risk.

Screening Context	Illustrative Sensitivity	Illustrative Specificity	Why Base Rate Matters
Screening mammography	About 77% to 95%	About 94% to 97%	Breast cancer prevalence in routine screening populations is much lower than in symptomatic groups, so false positives remain important.
HIV screening with modern lab testing	Typically above 99%	Typically above 99%	Even highly accurate testing still requires confirmatory algorithms because consequences of false positives are significant.
Colorectal stool-based screening	Varies by test type	Varies by test type	Programs are designed around follow-up colonoscopy precisely because no screening result should be interpreted without context.

These examples reinforce a key point: a test should never be judged by sensitivity or specificity alone. The target population matters. A tool that performs well in a high-risk clinic can appear much less convincing when deployed broadly among low-risk individuals. This is not because the test became worse. It is because the arithmetic of evidence changed.

How to Interpret the Calculator Results

When you use the calculator, focus on five outputs:

1. True positives: people correctly identified as having the condition.
2. False positives: people incorrectly flagged as having the condition.
3. True negatives: people correctly cleared.
4. False negatives: people who actually have the condition but were missed.
5. Positive predictive value: the chance a positive result is a true case.

If false positives are much larger than true positives, the scenario is vulnerable to Marylene’s fallacy. In that case, a positive result should be interpreted as a signal for further investigation, not as decisive proof. This is why good systems often use two-stage testing: an initial broad screen followed by a more specific confirmatory step.

Best Practices for Avoiding Marylene’s Fallacy

• Always ask for the base rate before interpreting a positive result.
• Translate percentages into expected counts per 1,000 or 10,000 people.
• Distinguish test accuracy metrics from post-test probability.
• Use confirmatory testing when the condition is rare or the stakes are high.
• Communicate results in plain language, especially to non-technical audiences.

Authoritative Resources

If you want to go deeper into risk interpretation, screening logic, and evidence-based health communication, these sources are excellent starting points:

• CDC: Breast Cancer Screening
• National Cancer Institute (.gov): Screening Overview
• Harvard T.H. Chan School of Public Health (.edu): Risk Science Center

Final Takeaway

Calcul Marylene’s fallacy is really about restoring the missing context to a probability judgment. A positive result is not just about the test. It is about the test plus the rarity of the event being tested for. Once prevalence is included, the meaning of the result often changes sharply. The calculator above makes that change visible, numerical, and intuitive. Whether you are reviewing a health screen, a fraud model, or a security alert, the lesson is the same: never confuse a test’s technical accuracy with the actual probability that a positive result is true.